| Name | Mennonite Home |
|---|---|
| Location | 5353 Columbus Street Se, Albany, Oregon |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 95 |
| Occupancy Rate | 69.26% |
| Medicare ID (CCN) | 385206 |
| Legal Business Name | Mennonite Home Of Albany, Inc |
| Ownership Type | Non Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Researchers involved in a large, multi-institutional study comparing the accuracy of positron emission tomography (PET) and computed tomography (CT) in the characterization of lung nodules found that PET was far more reliable in detecting whether or not a nodule was malignant.
A report from the anti-poverty group ActionAid finds that less than one-third of the $22 billion that was pledged to improve food security during a 2009 G8 meeting in L'Aquila, Italy, is from new funding sources, the U.K. Press Association reports (6/18).
Iroko Pharmaceuticals, LLC today reported the results of the Phase I clinical study of its unique formulation of naproxen, a widely used pain medication, using proprietary, patent protected nanotechnology.
Investigators reporting in the July issue of the Cell Press journal Cancer Cell have found that blocking a fundamental process deep within cancer cells can selectively kill them and spare normal cells.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 8.59 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.99 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 76.19 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.97 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.32 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.93 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.4 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.13 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.81 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 90.37 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.97 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 15.25 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 7.35 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.14 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.84 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 80.14 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.79 | 82.93 |
News Archive
Researchers involved in a large, multi-institutional study comparing the accuracy of positron emission tomography (PET) and computed tomography (CT) in the characterization of lung nodules found that PET was far more reliable in detecting whether or not a nodule was malignant.
A report from the anti-poverty group ActionAid finds that less than one-third of the $22 billion that was pledged to improve food security during a 2009 G8 meeting in L'Aquila, Italy, is from new funding sources, the U.K. Press Association reports (6/18).
Iroko Pharmaceuticals, LLC today reported the results of the Phase I clinical study of its unique formulation of naproxen, a widely used pain medication, using proprietary, patent protected nanotechnology.
Investigators reporting in the July issue of the Cell Press journal Cancer Cell have found that blocking a fundamental process deep within cancer cells can selectively kill them and spare normal cells.
› Verified 2 days ago